Sleep Apnea Testing for Women

Sleep Apnea Testing for Women

August 31, 2026 | |
Authored by

Key Takeaways

  • The diagnostic tools themselves were built around a male-typical presentation — decades of sleep apnea research focused disproportionately on middle-aged men, and the testing criteria in use today still reflect that starting point.
  • Hormones drive risk at specific, predictable life stages — pregnancy, PCOS, and especially menopause each change airway muscle tone and breathing control in ways that raise sleep apnea risk independent of weight or age alone.
  • Home sleep tests are measurably less accurate for women — research shows standard scoring criteria and unattended testing formats disproportionately miss the mild-to-moderate OSA patterns common in female patients, sometimes producing false negatives even when real disease is present.
There's already plenty of content covering the basics: women are more likely to go undiagnosed with sleep apnea than men, and their symptoms often look different — fatigue and mood changes instead of loud snoring. That's true, and worth knowing. But it undersells the actual scope of the problem.
 
The deeper issue isn't just that women present differently. It's that the tools used to diagnose sleep apnea — the testing thresholds, the scoring criteria, even the home sleep test technology itself — were developed and validated primarily on male-dominated research populations. That history is still baked into how sleep apnea gets diagnosed today, and it's a bigger factor in the underdiagnosis gap than symptom awareness alone.

The Hormonal Mechanics Behind Risk 

Most coverage of women and sleep apnea mentions menopause and moves on. The actual mechanics are more specific, and they matter because they point to exactly when risk changes and why.
  • Pregnancy. Rising progesterone during pregnancy actually has a protective effect on upper airway muscle tone for many women — but physical changes work against it. Weight gain, fluid retention that can swell nasal and throat tissue, and a growing uterus that reduces lung volume can all increase apnea risk, particularly in the third trimester. Sleep apnea during pregnancy is also linked to higher risk of gestational hypertension and preeclampsia, which is part of why sleep specialists increasingly recommend evaluation for women with risk factors during pregnancy specifically, not just after.
  • PCOS. Polycystic ovary syndrome involves hormonal patterns — including elevated androgens and insulin resistance — that independently raise sleep apnea risk, separate from weight. This means a younger woman with PCOS can have a real, elevated sleep apnea risk at an age and body type that wouldn't typically raise clinical suspicion using standard risk profiles.
  • Menopause. This is where the biggest, best-documented shift happens. Estrogen and progesterone both help maintain upper airway muscle tone and support stable respiratory drive during sleep. As those hormones decline during perimenopause and menopause, airway collapsibility increases — which is a core mechanical reason postmenopausal women see sleep apnea risk rise sharply, independent of any weight change. This is a hormonal and structural shift, not simply an aging or lifestyle effect.

The Testing Bias Not Often Discussed

This is the part that rarely makes it into consumer content, and it's arguably the most important piece: the way sleep apnea is measured may be under-detecting it in women specifically.
 
The hypopnea scoring threshold matters more than people realize. Sleep labs can score a hypopnea (a partial breathing reduction) using either a 3% or 4% oxygen desaturation criterion. Research comparing the two has found that switching from the stricter 4% threshold to the more sensitive 3% threshold increases OSA diagnosis rates in women by a substantial margin — in some studies, by well over 50% relative to the 4% criterion alone. In practice, this means the specific diagnostic standard a sleep lab or home test defaults to can be the difference between a woman being diagnosed or being told her results are normal.
 
Home sleep tests carry their own, separate bias. Standard at-home sleep apnea tests estimate total sleep time rather than measuring it directly (since they don't monitor brain activity like a lab polysomnogram does), which tends to underestimate AHI by roughly 15% across the board. But research specifically flags that this underestimation effect is worse for women, in part because a phenotype associated with a "low arousal threshold" — meaning the brain wakes a person up from very small breathing disruptions, before oxygen levels drop enough to register on a home test's sensors — appears to be more common in female patients. The result: some women who are experiencing real, disruptive breathing events during sleep produce a technically "normal" or falsely reassuring home test result, because the equipment is measuring the wrong signal for their specific pattern of disease.
 
What this means practically: a negative or borderline home sleep test is not necessarily the end of the story, especially for a woman with strong symptoms and risk factors. Requesting a formal in-lab polysomnogram, which captures brain activity and arousals directly, is a reasonable next step when symptoms and a "normal" home test result don't add up — and it's worth knowing that clinical guidance already recommends exactly this follow-up path for high-suspicion cases with a negative initial test.

Symptoms Worth Naming Specifically for Women

Beyond the well-covered basics (fatigue, insomnia, morning headaches), a few specific patterns are worth flagging because they're easy to misattribute to something else entirely:
  • Frequent nighttime bathroom trips that seem unrelated to fluid intake — sleep fragmentation from breathing events can trigger this independent of anything urinary
  • New or worsening restless leg symptoms alongside sleep complaints
  • Sleep that feels lighter or more fragmented than it used to, without an obvious cause like stress or a new medication
  • Depression or anxiety that a treatment plan (therapy, medication) doesn't fully explain or resolve — because the underlying sleep fragmentation is still there, undermining recovery from other angles
None of these symptoms are exclusive to sleep apnea, which is exactly why they're so often filed under something else — perimenopause, stress, aging, or a mood disorder — for years before anyone connects them back to breathing during sleep.

What to Do

If You Have PCOS

Raise sleep apnea specifically with your provider, even if your weight or age wouldn't typically prompt that conversation — the hormonal risk factor exists independent of both.

If You're Pregnant and Experiencing Snoring, Gasping, or Unusually Poor Sleep

Particularly in the third trimester, mention it at a prenatal visit rather than assuming it's a normal pregnancy symptom to wait out.

If You're Perimenopausal or Postmenopausal and dDealing with New Gatigue, Mood Changes, or Fragmented Sleep

Ask specifically whether a sleep evaluation makes sense — don't let it get filed under "just menopause" by default.

If a Home Sleep Test Comes Back Negative, But Your Symptoms are Strong

Ask about the scoring criteria used and whether an in-lab polysomnogram is warranted before accepting the result as final.

If You're Diagnosed and Pregnant, or Become Pregnant While Already on CPAP

Know that pressure needs often change during pregnancy and again postpartum — this is a normal part of therapy, not a sign something went wrong, and it's worth a follow-up titration rather than sticking with a pre-pregnancy setting indefinitely.

Conclusion

Sleep apnea in women isn't just underdiagnosed because of subtler symptoms — it's underdiagnosed partly because the diagnostic system itself has a built-in blind spot, shaped by the population it was originally designed and validated around. Hormonal shifts during pregnancy, PCOS, and especially menopause create real, mechanical changes in airway risk, and testing criteria don't always catch the pattern those changes produce. Knowing that isn't just informative — it's the difference between accepting a falsely reassuring test result and knowing when to push for a better one.
 
This content is for informational purposes only and is not a substitute for professional medical advice. Talk to your doctor or a sleep medicine specialist about your individual risk factors and testing options.

Recent posts

Share this Post


Chris Vasta

Chris Vasta is the president of The CPAP Shop and an expert in sleep and respiratory therapy. He often provides insights on product design and functionality on various manufacturers’ prototypes and is frequently tapped to provide reviews on new releases.